Zentalis Pharmaceuticals reported net income of -$42.29M for the quarter ended Jun 2026. This income statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 45.20M | 45.49M | 45.58M | 56.97M | 57.00M | 59.28M | 59.44M | 70.60M | 70.64M | 70.77M | 71.01M | 71.11M | 71.15M | 71.28M | 71.95M | 72.14M | 72.25M | 69.09M | 71.16M | 71.67M | ||||||||||
| Revenue & cost | ||||||||||||||||||||||||||||||
| Revenue | 40.56M | 26.86M | ||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 54.00M | 38.44M | 46.11M | 43.83M | 42.18M | 40.62M | 48.58M | 42.68M | 46.77M | 51.56M | 49.59M | 48.39M | 36.82M | 32.97M | 27.25M | 27.61M | 22.95M | 29.49M | 28.72M | 35.16M | ||||||||||
| Selling, General & AdministrativeSG&A | 8.87M | 9.75M | 11.77M | 19.64M | 12.01M | 11.14M | 16.37M | 15.66M | 15.95M | 16.36M | 15.74M | 16.76M | 14.61M | 40.01M | 10.58M | 8.45M | 10.78M | 7.91M | 9.14M | 9.23M | ||||||||||
| Restructuring CostsRestructuring | 7.80M | |||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 45.57M | 3.74M | -0.00M | |||||||||||||||||||||||||||
| Operating ExpensesOpex | 62.87M | 48.19M | 57.88M | 63.46M | 54.19M | 51.75M | 64.95M | 103.92M | 62.72M | 67.92M | 65.33M | 65.15M | 51.43M | 76.71M | 45.62M | 36.06M | 33.73M | 37.39M | 37.85M | 44.39M | ||||||||||
| Operating IncomeOp. Inc | -62.87M | -48.19M | -57.88M | -63.46M | -54.19M | -51.75M | -64.95M | -103.92M | -62.72M | -67.92M | -24.77M | -65.15M | -51.43M | -49.85M | -45.62M | -36.06M | -33.73M | -37.39M | -37.85M | -44.39M | ||||||||||
| EBIT | -62.87M | -48.19M | -57.88M | -63.46M | -54.19M | -51.75M | -64.95M | -103.92M | -62.72M | -67.92M | -24.77M | -65.15M | -51.43M | -49.85M | -45.62M | -36.06M | -33.73M | -37.39M | -37.85M | -44.39M | ||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | ||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.10M | 0.09M | 0.43M | 0.42M | 1.91M | 3.23M | 4.11M | 4.45M | 7.21M | 6.85M | 34.95M | -22.86M | 11.25M | 2.17M | -2.66M | 9.18M | 7.04M | 2.62M | 2.62M | 2.24M | ||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 51.58M | |||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||
| EBT | -11.19M | -48.10M | -57.45M | -63.04M | -52.29M | -48.52M | -60.84M | -99.47M | -55.51M | -61.07M | 10.18M | -88.01M | -40.19M | -47.68M | -48.28M | -26.87M | -26.69M | -34.77M | -35.23M | -42.15M | ||||||||||
| Tax ProvisionsTaxes | -0.70M | 0.16M | 0.03M | 0.02M | -0.16M | -0.36M | 0.11M | -0.60M | 0.03M | -0.14M | 0.14M | 0.27M | -0.03M | -0.20M | 0.44M | 0.12M | 0.14M | |||||||||||||
| Profit After TaxPAT | -10.49M | -50.09M | -59.24M | -68.39M | -54.50M | -54.98M | -63.26M | -112.56M | -55.54M | -60.94M | 10.07M | -88.28M | -40.16M | -47.47M | -48.28M | -26.87M | -26.69M | -35.22M | -35.35M | -42.29M | ||||||||||
| Equity Income | -1.83M | -1.75M | -5.34M | -2.37M | -6.82M | -2.31M | -13.70M | |||||||||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | -6.30M | -0.04M | -0.16M | -0.04M | -0.10M | -0.01M | -0.04M | -0.04M | -0.01M | -0.02M | -0.03M | |||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -10.49M | -48.26M | -57.49M | -63.05M | -52.13M | -48.16M | -60.95M | -98.86M | -55.54M | -60.94M | 10.04M | -88.28M | -40.16M | -47.47M | -48.28M | -26.87M | -26.69M | -35.22M | -35.35M | -42.29M | ||||||||||
| Consolidated Net IncomeConsol Net Inc. | -10.49M | -48.26M | -57.49M | -63.05M | -52.13M | -48.16M | -60.95M | -98.86M | -55.54M | -60.94M | 10.04M | -88.28M | -40.16M | -47.47M | -48.28M | -26.87M | -26.69M | -35.22M | -35.35M | -42.29M | ||||||||||
| Income towards Parent CompanyParent Net Inc | -10.49M | -48.26M | -57.49M | -63.05M | -52.13M | -48.16M | -60.95M | -98.86M | -55.54M | -60.94M | 10.04M | -88.28M | -40.16M | -47.47M | -48.28M | -26.87M | -26.69M | -35.22M | -35.35M | -42.29M | ||||||||||
| Net Income towards Common StockholdersNet Income | -10.49M | -48.26M | -57.49M | -63.05M | -52.13M | -48.16M | -60.95M | -98.86M | -55.54M | -60.94M | 10.04M | -88.28M | -40.16M | -47.47M | -48.28M | -26.87M | -26.69M | -35.22M | -35.35M | -42.29M | ||||||||||
| Additional items | ||||||||||||||||||||||||||||||
| EPS (Basic) | -0.24 | -1.13 | -1.27 | -1.23 | -0.92 | -0.91 | -1.03 | -1.63 | -0.79 | -0.93 | 0.14 | -1.24 | -0.56 | -0.67 | -0.67 | -0.37 | -0.37 | -0.49 | -0.50 | -0.59 | ||||||||||
| EPS (Diluted) | -0.24 | -1.13 | -1.27 | -1.23 | -0.92 | -0.91 | -1.03 | -1.63 | -0.79 | -0.93 | 0.14 | -1.24 | -0.56 | -0.67 | -0.67 | -0.37 | -0.37 | -0.49 | -0.50 | -0.59 | ||||||||||
| Shares Outstanding | 44.61M | 42.69M | 45.24M | 51.12M | 56.81M | 52.86M | 59.28M | 60.79M | 70.61M | 65.41M | 70.90M | 71.04M | 71.11M | 71.08M | 71.68M | 71.99M | 72.14M | 71.87M | 70.26M | 71.33M | ||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 44.61M | 42.69M | 45.24M | 51.12M | 56.81M | 52.86M | 59.28M | 60.79M | 70.61M | 65.41M | 71.19M | 71.04M | 71.11M | 71.08M | 71.68M | 71.99M | 72.14M | 71.87M | 70.26M | 71.33M | ||||||||||
| EBITDA | -62.87M | -48.19M | -57.88M | -63.46M | -54.19M | -51.75M | -64.95M | -103.92M | -62.72M | -67.92M | -24.77M | -65.15M | -51.43M | -49.85M | -45.62M | -36.06M | -33.73M | -37.39M | -37.85M | -44.39M | ||||||||||
| Interest ExpensesInt Expense | ||||||||||||||||||||||||||||||
| Tax Rate | 6.23 | -0.33 | -0.06 | -0.03 | 0.30 | 0.74 | -0.18 | 0.61 | -0.06 | 0.22 | 1.40 | -0.30 | 0.07 | 0.43 | -1.27 | -0.34 | -0.33 |